Moderna Statistics

Total Valuation

Moderna has a market cap or net worth of GBP 8.63 billion. The enterprise value is 3.03 billion.

Market Cap	8.63B
Enterprise Value	3.03B

Important Dates

The next estimated earnings date is Thursday, July 31, 2025.

Earnings Date	Jul 31, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	386.74M
Shares Outstanding	n/a
Shares Change (YoY)	+1.05%
Shares Change (QoQ)	+0.26%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	360.98M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	3.51
PB Ratio	1.11
P/TBV Ratio	1.12
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-1.17
EV / Sales	1.30
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-0.97

Financial Position

The company has a current ratio of 4.22, with a Debt / Equity ratio of 0.07.

Current Ratio	4.22
Quick Ratio	3.92
Debt / Equity	0.07
Debt / EBITDA	n/a
Debt / FCF	-0.19
Interest Coverage	-196.26

Financial Efficiency

Return on equity (ROE) is -29.34% and return on invested capital (ROIC) is -18.75%.

Return on Equity (ROE)	-29.34%
Return on Assets (ROA)	-15.84%
Return on Invested Capital (ROIC)	-18.75%
Return on Capital Employed (ROCE)	-33.59%
Revenue Per Employee	423,960
Profits Per Employee	-447,980
Employee Count	5,800
Asset Turnover	0.22
Inventory Turnover	27.39

Taxes

Income Tax	-37.93M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -76.73% in the last 52 weeks. The beta is 1.86, so Moderna's price volatility has been higher than the market average.

Beta (5Y)	1.86
52-Week Price Change	-76.73%
50-Day Moving Average	26.71
200-Day Moving Average	37.63
Relative Strength Index (RSI)	65.45
Average Volume (20 Days)	41,383

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	5.89

Income Statement

In the last 12 months, Moderna had revenue of GBP 2.46 billion and -2.60 billion in losses. Loss per share was -6.75.

Revenue	2.46B
Gross Profit	-2.03B
Operating Income	-2.89B
Pretax Income	-2.64B
Net Income	-2.60B
EBITDA	-2.74B
EBIT	-2.89B
Loss Per Share	-6.75

Full Income Statement

Balance Sheet

The company has 4.62 billion in cash and 576.62 million in debt, giving a net cash position of 5.92 billion.

Cash & Cash Equivalents	4.62B
Total Debt	576.62M
Net Cash	5.92B
Net Cash Per Share	n/a
Equity (Book Value)	7.79B
Book Value Per Share	20.13
Working Capital	4.00B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -2.36 billion and capital expenditures -752.32 million, giving a free cash flow of -3.11 billion.

Operating Cash Flow	-2.36B
Capital Expenditures	-752.32M
Free Cash Flow	-3.11B
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is -82.37%, with operating and profit margins of -117.37% and -105.67%.

Gross Margin	-82.37%
Operating Margin	-117.37%
Pretax Margin	-107.21%
Profit Margin	-105.67%
EBITDA Margin	-111.33%
EBIT Margin	-117.37%
FCF Margin	n/a

Dividends & Yields

Moderna does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-1.05%
Shareholder Yield	n/a
Earnings Yield	-30.09%
FCF Yield	-36.07%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Moderna has an Altman Z-Score of 7.39 and a Piotroski F-Score of 2.

Altman Z-Score	7.39
Piotroski F-Score	2